Search

Michael A. Matey

Examiner (ID: 10696, Phone: (571)270-5648 , Office: P/2835 )

Most Active Art Unit
2835
Art Unit(s)
2841, 2835
Total Applications
842
Issued Applications
659
Pending Applications
76
Abandoned Applications
122

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17732542 [patent_doc_number] => 20220218001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => REDOX ENZYMES IN ANIMAL FEED COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/441731 [patent_app_country] => US [patent_app_date] => 2020-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 177630 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17441731 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/441731
REDOX ENZYMES IN ANIMAL FEED COMPOSITIONS Apr 4, 2020 Pending
Array ( [id] => 17670155 [patent_doc_number] => 20220183322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => REDOX ENZYMES IN ANIMAL FEED COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/441714 [patent_app_country] => US [patent_app_date] => 2020-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 101895 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17441714 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/441714
REDOX ENZYMES IN ANIMAL FEED COMPOSITIONS Apr 4, 2020 Abandoned
Array ( [id] => 17548516 [patent_doc_number] => 20220119857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => Use of Muramic Acid as a Biomarker for Gastrointestinal Peptidoglycan Hydrolysis [patent_app_type] => utility [patent_app_number] => 17/434740 [patent_app_country] => US [patent_app_date] => 2020-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4921 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17434740 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/434740
Use of Muramic Acid as a Biomarker for Gastrointestinal Peptidoglycan Hydrolysis Mar 19, 2020 Pending
Array ( [id] => 18269220 [patent_doc_number] => 20230090462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => ISOLATION, ENRICHMENT AND EXPANSION OF CONE PROGENITOR CELLS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/439251 [patent_app_country] => US [patent_app_date] => 2020-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17535 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17439251 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/439251
ISOLATION, ENRICHMENT AND EXPANSION OF CONE PROGENITOR CELLS AND USES THEREOF Mar 15, 2020 Pending
Array ( [id] => 17689366 [patent_doc_number] => 20220196659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => METHOD FOR DETERMINING EFFICACY [patent_app_type] => utility [patent_app_number] => 17/435911 [patent_app_country] => US [patent_app_date] => 2020-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4944 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17435911 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/435911
METHOD FOR DETERMINING EFFICACY Mar 5, 2020 Pending
Array ( [id] => 16267403 [patent_doc_number] => 20200268890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-27 [patent_title] => Dosing Regimens For The Treatment Of Fabry Disease [patent_app_type] => utility [patent_app_number] => 16/806404 [patent_app_country] => US [patent_app_date] => 2020-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10296 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16806404 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/806404
Dosing Regimens For The Treatment Of Fabry Disease Mar 1, 2020 Abandoned
Array ( [id] => 17595708 [patent_doc_number] => 20220145282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => Cell-Free Compositions for ATP Regeneration and Uses Thereof [patent_app_type] => utility [patent_app_number] => 17/430634 [patent_app_country] => US [patent_app_date] => 2020-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8763 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430634 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/430634
Cell-Free Compositions for ATP Regeneration and Uses Thereof Feb 11, 2020 Abandoned
Array ( [id] => 17548419 [patent_doc_number] => 20220119760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => ISOLATED CELL CULTURE COMPONENTS AND METHODS FOR ISOLATING THE SAME FROM LIQUID CELL CULTURE MEDIUM [patent_app_type] => utility [patent_app_number] => 17/428063 [patent_app_country] => US [patent_app_date] => 2020-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14656 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428063 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/428063
ISOLATED CELL CULTURE COMPONENTS AND METHODS FOR ISOLATING THE SAME FROM LIQUID CELL CULTURE MEDIUM Feb 4, 2020 Pending
Array ( [id] => 17458806 [patent_doc_number] => 20220072110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => PLASMINOGEN FOR TREATING AND PREVENTING MICROTHROMBOSIS [patent_app_type] => utility [patent_app_number] => 17/422962 [patent_app_country] => US [patent_app_date] => 2020-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13818 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422962 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/422962
PLASMINOGEN FOR TREATING AND PREVENTING MICROTHROMBOSIS Jan 23, 2020 Pending
Array ( [id] => 15926137 [patent_doc_number] => 20200154702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => Stable Bioactive Substances and Methods of Making [patent_app_type] => utility [patent_app_number] => 16/751708 [patent_app_country] => US [patent_app_date] => 2020-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7449 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16751708 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/751708
Stable Bioactive Substances and Methods of Making Jan 23, 2020 Abandoned
Array ( [id] => 17441886 [patent_doc_number] => 20220062391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => ENHANCING EPITHELIAL OR ENDOTHELIAL BARRIER FUNCTION [patent_app_type] => utility [patent_app_number] => 17/420732 [patent_app_country] => US [patent_app_date] => 2020-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23390 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17420732 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/420732
ENHANCING EPITHELIAL OR ENDOTHELIAL BARRIER FUNCTION Jan 14, 2020 Abandoned
Array ( [id] => 16087499 [patent_doc_number] => 20200197736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-25 [patent_title] => BIOLOGICAL COMPOSITION FOR DEGRADING PLANT PESTICIDE RESIDUES AND THE APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 16/710545 [patent_app_country] => US [patent_app_date] => 2019-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2515 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16710545 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/710545
BIOLOGICAL COMPOSITION FOR DEGRADING PLANT PESTICIDE RESIDUES AND THE APPLICATION THEREOF Dec 10, 2019 Abandoned
Array ( [id] => 17095516 [patent_doc_number] => 20210283307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => METHOD FOR EXTRACTING EXTRACELLULAR MATRIX USING SUPERCRITICAL FLUID, AND EXTRACELLULAR MATRIX BIOMATERIAL FOR TISSUE REGENERATION PRODUCED THEREBY [patent_app_type] => utility [patent_app_number] => 17/257541 [patent_app_country] => US [patent_app_date] => 2019-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7334 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257541 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/257541
METHOD FOR EXTRACTING EXTRACELLULAR MATRIX USING SUPERCRITICAL FLUID, AND EXTRACELLULAR MATRIX BIOMATERIAL FOR TISSUE REGENERATION PRODUCED THEREBY Nov 21, 2019 Pending
Array ( [id] => 15931739 [patent_doc_number] => 20200157503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => HEMANGIO COLONY FORMING CELLS AND NON-ENGRAFTING HEMANGIO CELLS [patent_app_type] => utility [patent_app_number] => 16/690888 [patent_app_country] => US [patent_app_date] => 2019-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45534 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16690888 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/690888
HEMANGIO COLONY FORMING CELLS AND NON-ENGRAFTING HEMANGIO CELLS Nov 20, 2019 Abandoned
Array ( [id] => 15646411 [patent_doc_number] => 20200085735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-19 [patent_title] => Novel methods for delivering therapeutics agents to the eye via the nasal passages [patent_app_type] => utility [patent_app_number] => 16/690197 [patent_app_country] => US [patent_app_date] => 2019-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16339 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16690197 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/690197
Novel methods for delivering therapeutics agents to the eye via the nasal passages Nov 20, 2019 Pending
Array ( [id] => 17291029 [patent_doc_number] => 20210386868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => EXTRACELLULAR VESICLES FOR REPLACEMENT OF UREA CYCLE PROTEINS & NUCLEIC ACIDS [patent_app_type] => utility [patent_app_number] => 17/281535 [patent_app_country] => US [patent_app_date] => 2019-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16666 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17281535 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/281535
EXTRACELLULAR VESICLES FOR REPLACEMENT OF UREA CYCLE PROTEINS & NUCLEIC ACIDS Nov 17, 2019 Abandoned
Array ( [id] => 15616009 [patent_doc_number] => 20200078409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-12 [patent_title] => METHOD FOR TREATMENT OF INFERTILITY, PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFERTILITY AND METHOD FOR PRODUCING THE SAME [patent_app_type] => utility [patent_app_number] => 16/684142 [patent_app_country] => US [patent_app_date] => 2019-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5227 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16684142 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/684142
METHOD FOR TREATMENT OF INFERTILITY, PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFERTILITY AND METHOD FOR PRODUCING THE SAME Nov 13, 2019 Abandoned
Array ( [id] => 17343935 [patent_doc_number] => 20220010266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => Microbial hosts engineered for increased tolerance to temperature shifts [patent_app_type] => utility [patent_app_number] => 17/291620 [patent_app_country] => US [patent_app_date] => 2019-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12309 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291620 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/291620
Microbial hosts engineered for increased tolerance to temperature shifts Nov 7, 2019 Pending
Array ( [id] => 17292219 [patent_doc_number] => 20210388058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => METHOD FOR MANUFACTURING HIGHLY PURIFIED LACTOFERRIN AND LACTOPEROXIDASE FROM MILK, COLOSTRUM AND ACID OR SWEET WHEY [patent_app_type] => utility [patent_app_number] => 17/291081 [patent_app_country] => US [patent_app_date] => 2019-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8908 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291081 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/291081
METHOD FOR MANUFACTURING HIGHLY PURIFIED LACTOFERRIN AND LACTOPEROXIDASE FROM MILK, COLOSTRUM AND ACID OR SWEET WHEY Nov 5, 2019 Abandoned
Array ( [id] => 15832387 [patent_doc_number] => 20200131475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-30 [patent_title] => METHOD OF GENERATING NATURAL KILLER CELLS AND DENDRITIC CELLS FROM HUMAN EMBRYONIC STEM CELL-DERIVED HEMANGIOBLASTS [patent_app_type] => utility [patent_app_number] => 16/669931 [patent_app_country] => US [patent_app_date] => 2019-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7682 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16669931 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/669931
METHOD OF GENERATING NATURAL KILLER CELLS AND DENDRITIC CELLS FROM HUMAN EMBRYONIC STEM CELL-DERIVED HEMANGIOBLASTS Oct 30, 2019 Pending
Menu